Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

Centene fell by 11.1 percent week-on-week, from $31.44 on July 11 to $27.95 last Friday—a new all-time low, as investors turned cautious ahead of its second quarter earnings results, further ...

U.S. stocks advanced on Thursday as strong corporate earnings and upbeat economic data boosted market sentiment. PepsiCo and ...

Tariff risk remains alive: Bloomberg reports Trump is considering 10–15% tariffs on 150+ countries, mainly smaller trade partners. Meanwhile, the EU is preparing retaliatory tariffs on U.S. goods and ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), Alibaba Group ...

Molina's shares drop amid earnings warnings, Medicaid cuts, and cost pressures. Click here to read more about MOH stock and ...

Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

The 25% decline in Centene’s stock seems warranted given the substantial earnings adjustment and ongoing ambiguity.

The health-insurance provider is reckoning with multiple threats to its business, potentially leaving it with fewer and less-healthy enrollees signed up to its health-insurance plans.

The S&P 500 Index ($SPX) (SPY) today is up +0.25%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.67%. September E-mini S&P futures ...

In other recent news, Centene Corporation announced it is withdrawing its 2025 earnings guidance due to challenges with marketplace risk adjustments and rising Medicaid costs.